Search filters

List of works by Maria Vittoria Dieci

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

scientific article published on 2 August 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

scientific article published in September 2017

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

scientific article published on 01 March 2019

Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome

scientific article published on 16 November 2016

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

scientific article

Clinical development of mTOR inhibitors in breast cancer

scientific article published on 17 February 2014

Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology

scientific article published on 17 August 2018

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

scientific article published on 23 July 2008

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

scientific article published on 14 July 2020

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer ⬇️

scientific article published on January 21, 2012

Escalation and de-escalation in HER2 positive early breast cancer

scientific article published on 01 January 2019

Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary

article

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience

scientific article

Fat grafting for breast cancer patients: From basic science to clinical studies

scientific article

Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives

scientific article published on 15 February 2013

First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

scientific article

GD2 expression in breast cancer.

scientific article

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)

article

Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer

scientific article published in July 2017

Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.

scientific article published on 27 February 2018

Immune characterization of breast cancer metastases: prognostic implications.

scientific article

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.

scientific article published on 5 July 2016

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medica

scientific article published on 08 August 2019

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy

scientific article published on 25 February 2021

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

scientific article

Landscape and evolution of therapeutic research for breast cancer patients

scientific article

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.

scientific article

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer

scientific article published on 8 February 2011

Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agents

scientific article

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

scientific article published on 20 December 2012

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.

scientific article

New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancer.

scientific article

Olaparib for the treatment of breast cancer

scientific article published on 30 March 2018

PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype

scientific article published on 25 August 2020

PIK3CA: a Target or a Marker in Breast Cancers

Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center

scientific article published on 02 July 2018

Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

scientific article published on 27 December 2011

Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis

scientific article published on 03 March 2012

Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study

scientific article published on 09 January 2015

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives

scientific article published on 19 September 2019

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

scientific article published on 20 May 2015

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

scientific article published on 16 June 2017

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

scientific article published on 01 February 2019

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on 08 January 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on July 2015

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

scientific article

Quantification of residual risk of relapse in breast cancer patients optimally treated

scientific article published on August 2013

Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact

Rare breast cancer subtypes: histological, molecular, and clinical peculiarities

scientific article

Relapsed triple-negative breast cancer: challenges and treatment strategies

scientific article published on August 2013

The Future of Chemotherapy in the Era of Personalized Medicine

The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies

scientific article published on 30 October 2020

The immune system and hormone-receptor positive breast cancer: Is it really a dead end?

scientific article published on 28 March 2016

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

scientific article published on 01 August 2018

Timing for starting second-line therapy in recurrent ovarian cancer

scientific article published on January 2011

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

scientific article published on 16 January 2019

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

scientific article published on 13 March 2017

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o

article by Maria Vittoria Dieci et al published October 2018 in Seminars in Cancer Biology

Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study

scientific article published on 14 December 2019

Whole exome sequencing of rare aggressive breast cancer histologies.

scientific article

Paulina is supported by:

About Paulina

Help